港股异动 | 昭衍新药(06127)再涨超7% 实验猴价格迎来暴涨 供需缺口或持续放大

智通财经
Dec 11, 2025

智通财经APP获悉,昭衍新药(06127)再涨超7%,截至发稿,涨7.1%,报18.56港元,成交额4256.82万港元。

消息面上,据北京商报,实验猴价格迎来暴涨。12月9日从相关繁育厂商处了解到,目前3-5岁左右的食蟹猴价格已涨至14万元一只,且年内已出现供不应求的局面。据悉,昭衍新药为全球最大实验猴供应商。

根据方正证券测算,预计25-27年实验猴供给大约4.90-5.24万只/年,实验猴需求量大约5.13-6.26万只/年,该行认为短期由于新药研发回暖,驱动实验猴用量提升,而供给侧短期改善难度较大,供需缺口或持续放大。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10